Gilead Sciences Inc's antiviral remdesivir could be priced up to $5,080 per course based on benefits shown in COVID-19 patients, a U.S. drug pricing research group suggested on Wednesday, above its...
from NDTV News - World-news https://www.ndtv.com/world-news/us-group-raises-pricing-recommendation-for-gileads-remdesivir-in-covid-2251791
No comments:
Post a Comment